Leading drug manufacturer Johnson & Johnson is being sued for mismanagement of the company’s pharmacy plan. The lawsuit, which also names J&J’s pharmacy benefits manager (PBM) as a defendant, accuses the company of massively overpaying the PBM for generic prescription drugs. (J&J denies the allegations.)

Per HR Dive:

“The lawsuit used as an example the generic drug teriflunomide, which is used to treat multiple sclerosis. While a 90-pill prescription could be filled at a variety of common drugstores for prices ranging from around $28 to about $77, the complaint alleged, J&J “‘agreed to make their ERISA plans and their beneficiaries pay $10,239.69 — not a typo — for each 90-pill teriflunomide prescription.’” [Emphasis added]

If this can happen to a drugmaker’s pharmacy plan, how do you know that it’s not happening to you, too? Well, it won’t be if you’re using MedBen Rx. There is zero margin built into MedBen Rx pricing… no artificial markups, no hidden PBM profits.

With MedBen Rx, you can be confident that you’re paying the real price for prescription drugs. If you’re not using MedBen Rx, call us today at 888-627-8683 for a free, no-obligation, evaluation.